For example, patients need to eat more protein and participate in a strength training program to counteract some of the muscle loss associated with the GLP-1 drugs
Lastly, drug manufacturers are also studying the use of GLP-1s for the treatment of cardiovascular disease, as well as several other diseases that are often co-morbidities with diabetes (including heart failure, peripheral arterial disease, sleep apnea, and diabetic retinopathy)
An independent study stained 173 cutaneous sebaceous lesions for Lynch syndrome proteins (via IHC) in patients who were not known to have a Lynch syndrome diagnosis.[19] Fifty-three percent (92/173) of these cutaneous sebaceous lesions had abnormal IHC results
Once you are ready to proceed, Dr
Its unclear how safe the drugs would be for a person of normal weight, Klein said
Many individuals find their optimal balance at 0.5mg or 1.0mg and remain there long-term